Published in Gut on October 01, 2003
Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer | NCT02681601
Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol (2012) 2.45
Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett (2008) 2.05
Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer. Support Care Cancer (2007) 1.68
Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer (2004) 1.68
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer (2004) 1.51
Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract (2011) 1.45
Cancer cachexia--pathophysiology and management. J Gastroenterol (2013) 1.20
Fasting and differential chemotherapy protection in patients. Cell Cycle (2010) 1.18
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut (2005) 1.14
Regulation of muscle protein synthesis and the effects of catabolic states. Int J Biochem Cell Biol (2013) 1.10
Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer (2009) 1.09
The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer (2009) 1.09
Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy--a pilot study. Support Care Cancer (2004) 1.08
Cancer cachexia. Langenbecks Arch Surg (2004) 1.08
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. Oncologist (2010) 1.06
Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle (2011) 1.05
Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise. J Cachexia Sarcopenia Muscle (2011) 0.97
Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer (2011) 0.96
Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol (2015) 0.96
Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. Curr Treat Options Oncol (2010) 0.96
Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers. Mol Clin Oncol (2013) 0.95
Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur J Clin Nutr (2012) 0.92
Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer (2006) 0.89
Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer. Oncol Lett (2013) 0.89
Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax (2005) 0.89
Marine phospholipids--a promising new dietary approach to tumor-associated weight loss. Support Care Cancer (2009) 0.88
Nutritional therapy for cancer cachexia. Gut (2003) 0.88
Cancer cachexia: medical management. Support Care Cancer (2009) 0.87
Clinical impact of systematic nutritional care in adults submitted to allogeneic hematopoietic stem cell transplantation. Rev Bras Hematol Hemoter (2012) 0.86
Computational modeling of cancer cachexia. Curr Opin Clin Nutr Metab Care (2008) 0.86
Optimal management of cancer anorexia-cachexia syndrome. Cancer Manag Res (2010) 0.86
Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br J Cancer (2011) 0.85
Novel intriguing strategies attenuating to sarcopenia. J Aging Res (2012) 0.85
Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study. Br J Cancer (2005) 0.85
Artificial nutrition: principles and practice of enteral feeding. Clin Colon Rectal Surg (2004) 0.85
Nutritional interventions for cancer-induced cachexia. Curr Probl Cancer (2011) 0.85
Skeletal muscle atrophy is attenuated in tumor-bearing mice under chemotherapy by treatment with fish oil and selenium. Oncotarget (2015) 0.83
Plasma phospholipid PUFAs are associated with greater muscle and knee extension strength but not with changes in muscle parameters in older adults. J Nutr (2014) 0.83
Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report. Invest New Drugs (2010) 0.82
A systematic review of health-related quality of life instruments in patients with cancer cachexia. Support Care Cancer (2013) 0.81
Disease specific substrates in cancer cachexia - Reality and anticipation. Rep Pract Oncol Radiother (2012) 0.81
Treatment of cachexia in oncology. Indian J Palliat Care (2010) 0.79
Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway. Support Care Cancer (2006) 0.78
Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer. Support Care Cancer (2010) 0.78
New perspective for nutritional support of cancer patients: Enteral/parenteral nutrition. Exp Ther Med (2011) 0.78
Non-surgical oncology - Guidelines on Parenteral Nutrition, Chapter 19. Ger Med Sci (2009) 0.78
Fish oil and treatment of cancer cachexia. Genes Nutr (2008) 0.78
Pharmacology of manipulating lean body mass. Clin Exp Pharmacol Physiol (2015) 0.78
Energy metabolism and nutritional status in hospitalized patients with lung cancer. J Clin Biochem Nutr (2016) 0.78
Muscle function and omega-3 fatty acids in the prediction of lean body mass after breast cancer treatment. Springerplus (2013) 0.77
Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia. Theor Biol Med Model (2015) 0.76
n-3 Polyunsaturated Fatty Acids and their Role in Cancer Chemoprevention. Curr Pharmacol Rep (2015) 0.76
Nutrition in Pancreatic Cancer: A Review. Gastrointest Tumors (2016) 0.76
The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour. BMC Gastroenterol (2005) 0.76
Nutrition in cachexia: from bench to bedside. J Cachexia Sarcopenia Muscle (2016) 0.76
Effect of conjugated linoleic acid supplementation on quality of life in rectal cancer patients undergoing preoperative Chemoradiotherapy. Pak J Med Sci (2017) 0.75
Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients. Children (Basel) (2014) 0.75
Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial. Lipids Health Dis (2017) 0.75
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle (2017) 0.75
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med (1989) 5.02
Proceedings: Causes of death in cancer patients. Cancer (1974) 4.56
Characterization of a cancer cachectic factor. Nature (1996) 2.46
Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial. J Clin Oncol (2001) 2.39
Relationship between total body water and surface area in normal and obese subjects. J Clin Pathol (1971) 2.15
Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res (1991) 1.74
Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol (1993) 1.65
Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer (1997) 1.52
Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res (2001) 1.47
The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer (1999) 1.46
The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition (1996) 1.34
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer (2000) 1.22
A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol (1987) 1.19
Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (Lond) (1997) 1.15
The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am J Clin Nutr (2002) 1.10
Comparison of bio-impedance spectroscopy and multi-frequency bio-impedance analysis for the assessment of extracellular and total body water in surgical patients. Clin Sci (Lond) (1995) 1.08
Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. Clin Nutr (2002) 1.03
Hyperalimentation of the cancer patient with protein-calorie undernutrition. Cancer Res (1981) 1.02
The cancer cachexia syndrome. Surg Oncol Clin N Am (2001) 0.94
Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. J Clin Oncol (1996) 0.91
Randomized, dose-finding phase III study of lithium gamolenate in patients with advanced pancreatic adenocarcinoma. Br J Surg (2001) 0.88
Validation of the measurement of body composition from whole body bioelectric impedance. Infusionstherapie (1990) 0.83
Methods and validity of dietary assessments in four Scandinavian populations. Nutr Cancer (1982) 0.82
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 10.03
Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet (1995) 7.64
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care (2008) 6.79
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med (1994) 6.05
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging (2009) 5.98
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
DNA purification and isolation using a solid-phase. Nucleic Acids Res (1994) 4.90
Biology of cachexia. J Natl Cancer Inst (1997) 4.18
Attention modulates synchronized neuronal firing in primate somatosensory cortex. Nature (2000) 3.93
Accumulation of chlorpyrifos on residential surfaces and toys accessible to children. Environ Health Perspect (1998) 3.75
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol (1996) 3.68
Systematic review of enhanced recovery programmes in colonic surgery. Br J Surg (2006) 3.55
The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer (1994) 3.45
Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID). Nature (1990) 3.42
Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum. J Mol Biol (1996) 3.41
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.40
Systematic review of five feeding routes after pancreatoduodenectomy. Br J Surg (2013) 3.40
The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol (1992) 3.39
The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.37
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther (1997) 2.92
Intake of macronutrients and risk of breast cancer. Lancet (1996) 2.81
The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer (1999) 2.78
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res (1996) 2.76
A normal appendix found during diagnostic laparoscopy should not be removed. Br J Surg (2001) 2.71
Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis (1999) 2.66
Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc (1996) 2.54
Bowel injury as a complication of laparoscopy. Br J Surg (2004) 2.47
[Primary structure of transfer RNA]. Biochimie (1972) 2.43
Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg (1997) 2.43
Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis. Br J Surg (2004) 2.42
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
PillCam colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy (2006) 2.24
Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol (2001) 2.24
Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.22
A case-control study of gastric cancer and diet in Italy. Int J Cancer (1989) 2.17
Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum (1995) 2.15
Treatment of bile duct lesions after laparoscopic cholecystectomy. Gut (1996) 2.12
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer (2005) 2.09
Myopic children show insufficient accommodative response to blur. Invest Ophthalmol Vis Sci (1993) 2.08
Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.05
[Obstructive jaundice after surgery of the biliary tract, a benign stricture or not?]. Ned Tijdschr Geneeskd (2004) 2.05
The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol (2009) 2.04
[Changed diagnosis and treatment of hepatocellular carcinoma]. Ned Tijdschr Geneeskd (1996) 2.04
Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett (1987) 2.04
Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Res (1987) 2.03
[Laparoscopic cholecystectomy in day care; implementation of a guideline for clinical practice]. Ned Tijdschr Geneeskd (2003) 2.03
[Tumors in the gallbladder: a possible differentiation between malignant and benign tumours]. Ned Tijdschr Geneeskd (2007) 2.03
Meta-analysis of relaparotomy for secondary peritonitis. Br J Surg (2002) 2.02
Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. J Natl Cancer Inst (1987) 2.02
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet (2002) 2.01
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer (2004) 2.00
Choledochal cysts: age of presentation, symptoms, and late complications related to Todani's classification. J Pediatr Surg (2002) 1.99
Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients. Br J Cancer (1997) 1.95
Risk factors for bile duct injury in laparoscopic cholecystectomy: analysis of 49 cases. Br J Surg (1994) 1.91
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia (2001) 1.91
Measurement of children's exposure to pesticides: analysis of urinary metabolite levels in a probability-based sample. Environ Health Perspect (2001) 1.91
Regulation of adenylate cyclase synthesis in Escherichia coli: nucleotide sequence of the control region. EMBO J (1983) 1.89
Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc (1997) 1.88
Spontaneous secretion of interferon gamma and interleukin 4 by human intraepithelial and lamina propria gut lymphocytes. Gut (1998) 1.88
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Aliment Pharmacol Ther (2004) 1.87
A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research. Pharmacoeconomics (1996) 1.86
Suicide attempts in the Epidemiologic Catchment Area Study. Yale J Biol Med (1988) 1.86
Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.86
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85
Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients. Br J Surg (1997) 1.84
Systematic review and meta-analysis of the effectiveness of antibiotic prophylaxis in prevention of wound infection after mesh repair of abdominal wall hernia. Br J Surg (2006) 1.83
Hernia surgery changes in the Amsterdam region 1994-2001: decrease in operations for recurrent hernia. Hernia (2004) 1.81
IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization. J Clin Microbiol (1998) 1.80
Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.79
Effects of cytokines on the liver. Hepatology (1991) 1.76
Behavioral, health, and cost outcomes of an HMO-based prenatal health education program. Public Health Rep (1984) 1.74
Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res (1991) 1.74
Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol (1997) 1.72
Impaired quality of life 5 years after bile duct injury during laparoscopic cholecystectomy: a prospective analysis. Ann Surg (2001) 1.71
Atlantoaxial instability in Down syndrome--guidelines for screening and detection. J R Soc Med (1990) 1.71
Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region. Br J Surg (1995) 1.70
Oxygen sensing in the body. Prog Biophys Mol Biol (2005) 1.70
Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.69
Bacterial translocation in multiple organ failure: cause or epiphenomenon still unproven. Br J Surg (1997) 1.69
Predictors of MCAT scores for black Americans. J Natl Med Assoc (1987) 1.68
Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer (1997) 1.68
Quantitative analysis of the functionality and efficiency of three surgical dissection techniques: a time-motion analysis. J Laparoendosc Adv Surg Tech A (1999) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer (1995) 1.66
The cya locus of Escherichia coli K12: organization and gene products. Mol Gen Genet (1982) 1.66
The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris. Dermatology (2001) 1.66
On the association between valproate and polycystic ovary syndrome. Epilepsia (2001) 1.65
Cleavage of zearalenone-glycoside, a "masked" mycotoxin, during digestion in swine. Zentralbl Veterinarmed B (1990) 1.64
Quality of life assessment in daily clinical oncology practice: a feasibility study. Eur J Cancer (1998) 1.64
Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol (1996) 1.64
Readmissions after pancreatoduodenectomy. Br J Surg (2001) 1.64
Incidence and management of pancreatic leakage after pancreatoduodenectomy. Br J Surg (2005) 1.64